New, Study

A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Precision Diabetes, Inc. North Carolina

en | boerse | 67935276 |